TY  - GEN
AU  - Dreicer,Robert
AU  - MacLean,David
AU  - Suri,Ajit
AU  - Stadler,Walter M
AU  - Shevrin,Daniel
AU  - Hart,Lowell
AU  - MacVicar,Gary R
AU  - Hamid,Omid
AU  - Hainsworth,John
AU  - Gross,Mitchell E
AU  - Shi,Yuanjun
AU  - Webb,Iain J
AU  - Agus,David B
TI  - Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer
SN  - 1557-3265
PY  - 2014///1028
KW  - Aged
KW  - Aged, 80 and over
KW  - Humans
KW  - Imidazoles
KW  - pharmacology
KW  - Male
KW  - Middle Aged
KW  - Naphthalenes
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Prostate-Specific Antigen
KW  - blood
KW  - Prostatic Neoplasms, Castration-Resistant
KW  - drug therapy
KW  - Steroid 17-alpha-Hydroxylase
KW  - antagonists & inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-13-2436
ER  -